Day: December 14, 2022

MIAMI BEACH, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced the final results of the Special Meeting of Stockholders (“Special Meeting”) held on December 9, 2022. According to the certified voting results provided by the Independent Inspector of Elections, a significant majority of Pasithea stockholders rejected all of the proposals asserted by a dissident group of stockholders. Of the votes cast at the Special Meeting, approximately 67% rejected the proposals to remove the Company’s directors, representing approximately 12.7 million shares or approximately 44% of the total outstanding shares. As a result,...

NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY IN WHOLE OR IN PART IN THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA, BELARUS OR ANY JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Maha Energy AB (publ) (“Maha” or the “Company”) has, in accordance with the Company’s press release earlier today, completed an accelerated bookbuilding procedure and resolved on a directed new share issue of 23,900,000 shares at a subscription price of SEK 8.5 per share (the “Directed New Share Issue”). The subscription price for the shares in the Directed New Share Issue has been determined through an accelerated bookbuilding procedure carried out...

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) today provided an update regarding the successful completion of the maintenance shutdown and recommissioning of its electrolytic zinc processing facility (the “Processing Facility”) located in Salaberry-de-Valleyfield, Quebec. As previously announced, the Fund temporarily shut down operations to proceed with a proactive cell repair program and a cell-by-cell integrity assessment aimed at mitigating risk in the cellhouse. The shutdown lasted approximately six weeks, following which the facility went through a recommissioning phase. The Fund expects to benefit from the findings of its cell-by-cell integrity assessment as it continues the execution of its repair and maintenance program. “Various levels of repairs were made to the cells in the cellhouse...

RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that the December 13th, 2022, Annual Meeting is being adjourned until January 12th, 2023, to provide stockholders with additional time to vote on Proposal 1, approval of an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares of Common Stock. This vote, which requires approval by a majority of the outstanding shares, is required to proceed with the proposed merger with Viewpoint Molecular Targeting, Inc. The Board of Directors, as well as leading proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co.,...

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) announced today that a special meeting of unitholders (the “Meeting”) will be held on March 28, 2023 in response to the meeting requisition notice received from certain unitholders, including Riverstyx Capital Management and LM Asset Fund Limited Partnership, dated November 24, 2022. Over the last week, independent members of the Board of Trustees (the “Board”) of the Noranda Operating Trust (the “Trust”) initiated engagement with Riverstyx Capital Management and LM Asset Fund Limited Partnership. The goal was to come to a shared understanding and identify a mutually agreeable path forward. While no such path as yet has been agreed, the Trust’s Board regularly engages in conversations with unitholders and remains open to maintaining a dialogue...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it has closed the second tranche (the “Second Tranche”) of its previously announced non-brokered private placement financing (the “Offering”). An aggregate of 2,500,000 common shares (the “Common Shares”) were sold under the Second Tranche at a price of C$0.05 per Common Share for aggregate gross proceeds of approximately C$125,000. Euro Sun intends to use the proceeds of the Offering for general corporate purposes. All securities issued in connection with the Offering are subject to a statutory hold period of four-months and one day. The...

PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) — Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PT / 12:45 p.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company’s investor relations website at investors.embecta.com. About embecta embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com. CONTACTS  Investors:Pravesh...